TABR Capital Management LLC has acquired 30,100 shares of Bristol Myers Squibb Company, marking a new $1.62 million investment. This move signals a fresh position in the pharmaceutical giant by the investment firm.
TABR Capital Management Initiates $1.62 Million Stake in Bristol Myers Squibb
|1 min read
pharmaceuticalsinstitutional investmentequity holdingsBMY
